Pain and Fever Relief Drugs Markets in China

Publisher Name :
Date:1-Jun-2014
No. of pages: 198

China’s demand for Pain and Fever Relief Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China’s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.

Pain and Fever Relief Drugs Markets in China

Table Of Contents

I. Introduction
Report Scope and Methodology
Executive Summary

II. Business Environment
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. Pain and Fever Relief Drugs Industry Assessments
Pain and Fever Relief Drugs Industry Structure
Market Size
Market Growth Drivers
Pain and Fever Relief Drugs Sales Volume
Major Producer Facility Locations
Major Producers' Sales Volume and Market Share
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development

IV. Pain and Fever Relief Drugs Production and Demand
Market Overview by Drugs Classification
Aspirin
Paracetamol
Naproxen
Ibuprofen
Diclofenic Acid
Metamizole Sodium
Pain and Fever Relief Drugs Export
Market Overview by Price Interval
Market Overview by Producers and Their Brand
Pricing Trend

V. Pain and Fever Relief Drugs Market Outlook
Pain and Fever Relief Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. Marketing Strategies
China Market Entry Overview
China's Distribution System
Pain and Fever Relief Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
China's Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises

VII. Pain and Fever Relief Drugs Producer Directory
Profiles of Pain and Fever Relief Drugs Producers and Major Consumption in Industry

List Of Tables

I. Introduction
Economic Outlook Summary

II. Business Environment
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. Pain and Fever Relief Drugs Industry Assessments
Pain and Fever Relief Drugs Sales Volume by Curative Effect Classification
Pain and Fever Relief Drugs Major Producer, Their Brands, Their Sales Volume and Market Share
Pain and Fever Relief Drugs Sales Volume by Drugs Classification
Major Producer Facility Location
Major Material Drugs Producer Facility Location
Major Pain and Fever Relief Drugs Producer Sales Volume and Market Share
Pain and Fever Relief Drugs Major Producers' Sales Volume and Market Share
Major Foreign Investment in China

IV.Pain and Fever Relief Drugs Production and Demand
Pain and Fever Relief Drugs Sales Volume by Drugs Classification
Aspirin Major Producers' Sales Volume and Market Share
Paracetamol Major Producers' Sales Volume and Market Share
Naproxen Major Producers' Sales Volume and Market Share
Ibuprofen Major Producers' Sales Volume and Market Share
Diclofenic Acid Major Producers' Sales Volume and Market Share
Metamizole Sodium Major Producers' Sales Volume and Market Share
Pain and Fever Relief Drugs Export by Drugs Classification
Pain and Fever Relief Drugs Export by Curative Effect Classification
Pain and Fever Relief Drugs Sales Volume by Price Classification
Pain and Fever Relief Drugs Major Producer, Sales Volume and Market Share
Pain and Fever Relief Drugs Major Producer and Their Brands

V. Pain and Fever Relief Drugs Market Outlook
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

List Of Charts

I. Introduction
Pain and Fever Relief Drugs Sales Volume

II. Business Environment
China's GDP and Growth Rate
Industrial Output by Ownership
China's Imports and Exports

III. Pain and Fever Relief Drugs Industry Assessments
Pain and Fever Relief Drugs Sales Volume
Pain and Fever Relief Drugs Sales Volume by Drugs Classification
Pain and Fever Relief Drugs Sales Volume

IV. Pain and Fever Relief Drugs Production and Demand
Total Pain and Fever Relief Drugs Sales Volume
Pain and Fever Relief Drugs Sales Volume by Drugs Classification
Pain and Fever Relief Drugs Export
Aspirin Sales Volume and Market Share
Paracetamol Sales Volume and Market Share
Naproxen Sales Volume and Market Share
Ibuprofen Sales Volume and Market Share
Diclofenic Acid Sales Volume and Market Share
Metamizole Sodium Sales Volume and Market Share
Pain and Fever Relief Drugs Export by Drugs Classification
Aspirin Export and Market Share
Paracetamol Export and Market Share
Naproxen Export and Market Share
Ibuprofen Export and Market Share
Diclofenic Acid Export and Market Share
Metamizole Sodium Export and Market Share
Pain and Fever Relief Drugs Sales Volume by Price Classification

VI. Marketing Strategies
China's Distribution Channel

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018
  • New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

  • Global Biosimilars Market to Grow at a CAGR of 8.3%, to reach $262 billion by 2019
  • Lucrative Biosimilars Space to Erode Biologics Market from 2019, says GlobalData The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking …

  • Saudi Pharmaceutical Market worth $5.9 billion by 2020
  • A high burden of chronic diseases, improving regulatory guidelines and the launch of new products will provide the necessary impetus for the growth of the pharmaceutical market in Saudi Arabia The Saudi pharmaceutical market is one of the largest markets …

  • 2014 Deep Research Report on Global and China Intravenous Catheter Industry
    Published: 22-Jul-2014        Price: US $2200 Onwards        Pages: 184
    This is a professional and depth research report on China Intravenous Catheter industry. The report firstly introduced Intravenous Catheter basic information included Intravenous Catheter definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Intravenous Catheter industry policy and plan, Intravenous Catheter product specification, man......
  • 2014 Deep Research Report on Global and China Particulate Respirators Industry
    Published: 19-Jul-2014        Price: US $2200 Onwards        Pages: 150
    This is a professional and depth research report on Global and China Particulate Respirators industry. The report firstly introduced Particulate Respirators basic information included Particulate Respirators definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Particulate Respirators industry policy and plan, Particulate Respirators product specif......
  • 2014 Deep Research Report on Global and China Sialic Acid Industry
    Published: 19-Jul-2014        Price: US $2200 Onwards        Pages: 136
    This is a professional and depth research report on Global and China Sialic Acid industry. The report firstly introduced Sialic Acid basic information included Sialic Acid definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Sialic Acid industry policy and plan, Sialic Acid product specification, manufacturing process, cost structure etc. then sta......
  • OpportunityAnalyzer: Dengue Vaccines – Opportunity Analysis and Forecasts to 2020
    Published: 17-Jul-2014        Price: US $5995 Onwards        Pages: 189
    Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to be responsible for upwards of 100 million infections each year, DENV is the most prevalent arthropod-borne virus in the world. Individuals infected with DENV can present with a wide spectrum of symptoms, including fevers, retro-orbital pain, severe headache, muscle and joint pain, and rash. The severity of dengue fever ranges......
  • Greece Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 116
    BMI View: The Greek pharmaceutical and healthcare sector will continue contract over the medium-tolong term. Although Greece's financial outlook has stabilised and debts are being paid down, the government will continue to target the pharmaceutical and healthcare industry to reduce public spending. We highlight, however, that the generic drug sector and private healthcare industry will present some growth opportunities in the country. Headline Expenditure Projections ? Pharmaceuticals: EUR......
  • Lithuania Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 97
    BMI View: We expect the Lithuanian pharmaceutical market to post a five-year compound annual growth rate (CAGR) of 3.8%, rising to a value of LTL2.11bn (USD732mn) in 2018. The upcoming switch to the euro promises to boost purchasing power and stabilise the pharmaceutical market, albeit at the cost of increasing healthcare expenditure. Ceding control of monetary policy to Brussels leaves Lithuania with little leeway to increase its healthcare spending dramatically over the next five years. Th......
  • Moldova Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 96
    BMI View: BMI has upgraded its forecast for Moldova's pharmaceutical and healthcare market for 2014 due to improved economic conditions. Moldova is likely to sign the Association Agreement with the EU in June 2014, which would strengthen the business environment and improve the regulatory structure and access to the pharmaceutical market in the country. Moldova is undertaking a reform of its healthcare sector with the World Bank, which is likely to be positive for the sector. Any retaliatory......
  • Serbia Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 132
    The new Serbian government is actively trying to stabilise the country's fiscal position through cutting spending, encouraging outside investment and demand pickup for Serbian exports in order to reduce its debt burden. However, pharmaceutical spending is also a target for cuts. Local drug makers are set to feel the worst of these new measures as they cannot compete on cost compared to larger players in the market. The Serbian government has amended the Medicines Act with the specific aim of......
  • Slovakia Pharmaceuticals and Healthcare Report Q3 2014
    Published: 16-Jul-2014        Price: US $1295 Onwards        Pages: 113
    BMI View: The Slovakian government is planning to allocate EUR278mn (USD386.7mn) in EU funding to develop healthcare and medical infrastructure in Slovakia over the 2014-2020 period, reports news agency TASR. The government added that after adding contributions from the state budget, the total funds that have been allocated for developing healthcare infrastructure will be EUR300mn (USD417.3mn). The government plans to allocate these funds to projects in large university hospitals and develop......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs